1. Home
  2. HTBK vs CMPX Comparison

HTBK vs CMPX Comparison

Compare HTBK & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HTBK

Heritage Commerce Corp

HOLD

Current Price

$11.41

Market Cap

667.4M

Sector

Finance

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$5.53

Market Cap

752.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HTBK
CMPX
Founded
1997
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
667.4M
752.4M
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
HTBK
CMPX
Price
$11.41
$5.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
10
Target Price
$11.88
$13.44
AVG Volume (30 Days)
366.9K
2.2M
Earning Date
01-22-2026
11-05-2025
Dividend Yield
4.55%
N/A
EPS Growth
N/A
N/A
EPS
0.70
N/A
Revenue
$187,676,000.00
N/A
Revenue This Year
$13.16
N/A
Revenue Next Year
$7.61
N/A
P/E Ratio
$16.31
N/A
Revenue Growth
10.94
N/A
52 Week Low
$8.09
$1.33
52 Week High
$11.44
$5.86

Technical Indicators

Market Signals
Indicator
HTBK
CMPX
Relative Strength Index (RSI) 68.98 67.47
Support Level $11.06 $5.13
Resistance Level $11.48 $5.86
Average True Range (ATR) 0.26 0.32
MACD 0.06 0.03
Stochastic Oscillator 94.74 72.12

Price Performance

Historical Comparison
HTBK
CMPX

About HTBK Heritage Commerce Corp

Heritage Commerce Corp operates as a bank holding company. The company, through its subsidiary, offers commercial banking services to small and medium-sized businesses and their owners, managers, and employees. It operates through two reportable segments, namely Banking and Factoring. A majority of its revenue is generated from the Banking segment, which provides various loan products, including commercial and industrial loans, commercial real estate loans, construction loans, etc. This segment also focuses on deposit generation on relationship accounts, encompassing non-interest bearing demand, interest bearing demand, money market accounts, certificates of deposit, and savings accounts.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

Share on Social Networks: